Michael Reeves

Cybersecurity Analyst | Retired Professor of Neuroscience | Crypto Analyst | Exploring the intersection of technology, healthcare, and digital assets.

[Michael Reeves @MichaelReevs5]

Here are some good pieces of advice for cryptocurrency:

1. Research: Educate yourself about different cryptocurrencies, their technology, and their potential use cases before investing.

2. Diversify: Spread your investments across different cryptocurrencies to reduce risk.

3. Secure your holdings: Use secure wallets and enable two-factor authentication to protect your investments from theft.

4. Stay updated: Keep abreast of market trends, regulatory developments, and security threats to make informed decisions.

5. Only invest what you can afford to lose: Cryptocurrency markets can be highly volatile, so only invest money you can afford to lose without impacting your financial stability.

6. Avoid FOMO (Fear of Missing Out): Don't make impulsive investment decisions based on hype or speculation; always do your due diligence.

7. Long-term perspective: Consider holding onto your investments for the long term, rather than trying to time the market for short-term gains.

8. Beware of scams: Be cautious of fraudulent schemes, phishing attempts, and Ponzi schemes that prey on cryptocurrency investors.

[Michael Reeves @MichaelReevs5]

It really is extraordinary. Maintaining viable brain organoids for more than five years allows researchers to observe stages of human neural development that short term models cannot capture. It feels like science fiction, but the implications for studying neurological disease are very real.

[Michael Reeves @MichaelReevs5]

AI is changing penetration testing, but speed is not assurance. Keep agents least-privileged, protect credentials, verify outputs and use deterministic tools for precision.

[Teri Radichel #cybersecurity #ai #pentesting @TeriRadichel]

How I Use AI for Penetration Testing. Presentation at the AWS Security Community Day at the Computer History Museum on YouTube

https://t.co/hP5kPanmUX

[Michael Reeves @MichaelReevs5]

A major step in modelling human brain development beyond its earliest stages. Long-lived organoids could transform how we study neurological disease.

[nature @Nature]

Researchers have grown brain organoids that mirror the development of the human brain for more than five years

https://t.co/AefmRgesUY

[Michael Reeves @MichaelReevs5]

@Nature Remarkable work. These organoids did more than survive for five years: they retained developmental timing and acquired postnatal molecular features. #Neuroscience

[Michael Reeves @MichaelReevs5]

@DefiDragans It really is. I fully support continued research into these repurposed medicines and hope this leads to larger clinical trials.

[Michael Reeves @MichaelReevs5]

Well done 👏

[Han @jghvanwees]

🔻BREAKING NEWS: First in the World IVERMECTIN, Mebendazole and Fenbendazole Protocol for CANCER has been peer-reviewed & published!

The NEWS is spreading, our paper is everyplace lately! 😃

BIG PHARMA is attacking our Fenbendazole paper on 3 Stage 4 Cancer patients now Cancer Free! It will be resubmitted and published soon!

Well I have recently been attacked by Canadian authorities for my revolutionary Cancer research and work but ...

NEW FLORIDA CANCER CLINIC ON THE HORIZON!🙏

Thank you all for your continued support!! 😃

God Bless you all and God Bless those that are fighting Cancer...

SHARE !

⟁

https://t.co/ZdR8rvdlYg

[Michael Reeves @MichaelReevs5]

@MasteriasTrades Absolutely. Repurposed medicines deserve serious attention and proper clinical investigation. This research needs to continue.

[Michael Reeves @MichaelReevs5]

Could our neural activity become the next biometric signature? Early EEG research shows real potential, but long-term reliability will determine its future. #ComputationalNeuroscience

[Frontiers - Neuroscience @FrontNeurosci]

New Research: Extraction of brainprint by means of autoencoder with attention mechanism https://t.co/WHLKiRmGiA #FrontiersIn #ComputationalNeuroscience

[Michael Reeves @MichaelReevs5]

@FrontNeurosci Promising work on EEG brainprints. The key clinical test is whether identification remains stable despite disease, medication, stress and sleep changes. #EEG #Neuroscience

[Michael Reeves @MichaelReevs5]

@sciqst @FrontNeurosci A strong design would combine neuron specific and microglia specific conditional Cnr2 knockouts with bone marrow chimeras to distinguish resident microglia from infiltrating immune cells. Cell specific rescue and spatial transcriptomics could then test causality.

[Michael Reeves @MichaelReevs5]

Exciting progress in cannabinoid research. CB2 receptor signalling may regulate neuroinflammation, microglial activity, neuronal survival and cognition without the psychotropic effects associated with CB1. The evidence is largely preclinical, but the potential for targeted therapies is compelling.

[Michael Reeves @MichaelReevs5]

@CNS_Update Excellent initiative. 👏 Leadership in neurosurgery extends beyond technical excellence in the operating room. It requires sound clinical judgment, multidisciplinary collaboration, ethical decision making, accountability and a sustained commitment to patient safety and outcomes.

[Michael Reeves @MichaelReevs5]

Criticizing failures in healthcare is valid, but describing doctors collectively as unintelligent is disrespectful and achieves nothing. Patients deserve to be heard and clinicians must be accountable, but meaningful reform requires evidence, transparency and mutual respect, not blanket insults.

[Michael Reeves @MichaelReevs5]

@FrontNeurosci Fascinating review. Volume electron microscopy shows that nerve repair is more than axon regrowth. After peripheral nerve injury, mitochondria enter the axon initial segment, the ER reorganizes and ER membrane contacts increase. Important insight, though not yet a human therapy.

[Michael Reeves @MichaelReevs5]

@TheCyberSecHub The Azure claims remain unconfirmed, but the wider warning is well supported. Medusa has exceeded 500 victims, critical flaws are being exploited and AI is compressing attack time. Security now depends on rapid patching, strong identity controls and tightly restricted AI agents.

[Michael Reeves @MichaelReevs5]

AI is lowering the skill barrier to cybercrime and increasing the speed and scale of attacks. Smaller organizations may not need enormous budgets, but they do need strong fundamentals: multifactor authentication, rapid patching, restricted access, reliable backups and tested incident response.

[Han @jghvanwees]

🔻BREAKING NEWS: First in the World IVERMECTIN, Mebendazole and Fenbendazole Protocol for CANCER has been peer-reviewed & published!

The NEWS is spreading, our paper is everyplace lately! 😃

BIG PHARMA is attacking our Fenbendazole paper on 3 Stage 4 Cancer patients now Cancer Free! It will be resubmitted and published soon!

Well I have recently been attacked by Canadian authorities for my revolutionary Cancer research and work but ...

NEW FLORIDA CANCER CLINIC ON THE HORIZON!🙏

Thank you all for your continued support!! 😃

God Bless you all and God Bless those that are fighting Cancer...

SHARE !

⟁

https://t.co/ZdR8rvdlYg

[Frontiers - Neuroscience @FrontNeurosci]

New Research: The relevance of cannabinoid receptor 2 in the central nervous system: an update over the last 3 years https://t.co/wwK4qZqM8p #FrontiersIn #BehavioralNeuroscience

[CNS @CNS_Update]

The Leadership Institute convened this past Thursday and Friday with our 3 cohorts in Chicago, IL! Attendees heard from expert faculty and gained valuable insights into neurosurgical leadership.
#CNSCourse #leadership #neurosurgeons

[Journal of Neuro-Oncology @JNeurooncol]

Kraus et al. found that surgery for motor cortex brain metastases was not associated with worse functional outcomes and may offer greater long-term motor improvement than stereotactic radiotherapy. Read more here: https://t.co/tIJinmDvjG
#Neurosurgery #NeuroOncology